Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc (JAZZ), sold 6,000 shares at $186.09 ($1.1M) on 2026-03-03, disclosed to the SEC on 2026-03-04.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.09 | 3,159 | $588K | 52.6% |
| 2 | $186.73 | 2,608 | $487K | 43.5% |
| 3 | $187.84 | 233 | $44K | 3.9% |
| Total | $186.44 avg | 6,000 | $1.1M | 100% |
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |